About
History
Objective
Committee
Presidents
Membership Information
Legacy of Feng Pao Hsii
Lecturers
Scholarship Fund
Educational Grant
SSR-APLAR Fellowship
Events
CME
Social Events
Conferences
Latest Conferences
Upcoming Conferences
Resources
Training and Education
About
History
Objective
Committee
Presidents
Membership Information
Legacy of Feng Pao Hsii
Lecturers
Scholarship Fund
Educational Grant
SSR-APLAR Fellowship
Events
CME
Social Events
Conferences
Latest Conferences
Upcoming Conferences
Resources
Training and Education
Member’s Area
Login
GET IN TOUCH
Contact Us
About
History
Objective
Committee
SSR Presidents
Legacy of Feng Pao Hsii
Lecturers
Scholarship Fund
Educational Grant
SSR-APLAR Fellowship
Events
CME
Social Events
Conferences
Latest Conferences
Upcoming Conferences
Resources
Training and Education
Log In
Log Out
Contact Us
September 22, 2021
The place of the JAK inhibitor (tofacitinib citrate) in the RA treatment paradigm
Time:
6:00 - 7:00 pm
Foreign Speakers:
Prof Hendrik Schulze-Koops
Prof Gerd Burmester
Other Events
The complexity and paradigm shift in the management of PsA
Rheum@SEA Webinar in Rheumatoid Arthritis
Going Beyond As Remission Matters : Long-term Treatment Results with JAK Inhibitors in RA
Managing Co-Morbidities in Rheumatoid Arthritis in the New Decade
